Sense will be attending the Biotech Showcase 2019 in San Francisco from the 7th - 9th of January. If you would like to meet with us at the event please email to firstname.lastname@example.org
Sense have featured in a news article profiling cutting edge companies in Business and Innovation magazine.
3rd August 2018, Oxford, UK and Cambridge, UK. Sense Biodetection Limited (Sense) has today announced the appointment of Heiner Dreismann as non-executive Chairman. Heiner was previously the President and CEO of Roche Molecular Systems, the world leader in molecular diagnostics
27th April 2018, Oxfordshire, UK. Sense Biodetection Limited (Sense) has today announced that it has strengthened its senior team with the appointments of Dr Gemma Blackwell as Principal Scientist and Mr Lelio Cereda as Head of Development.
5 th December 2017, Oxfordshire, UK. Sense Biodetection Limited (Sense) has today announced that it has opened a new development facility near Cambridge, UK. The new site will serve as the home to the company’s design, development and production activities under the leadership of Chief Development Officer, Ralph Lamble. The facility complements Sense’s existing molecular laboratory facilities near Oxford, UK, and provides the company with the infrastructure necessary to develop and commercialise its highly innovative clinical diagnostic products.
4 th October 2016. Oxfordshire, UK. Sense Biodetection Limited (Sense) has today announced the formation of an advisory panel comprising a number of industry leading figures who will support the company through its next important stages of growth.
8th June 2016. Oxfordshire, UK. Sense Biodetection Limited (Sense) has today announced that is has completed a c.£508,000 oversubscribed seed investment round headed by leading technology investor, Mercia Fund Management. The investment will allow Sense to continue to establish its technology portfolio and support the further development and clinical evaluation of its first products.